Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions reflect cautious optimism, as commenters mention the potential benefits while also emphasizing the need for further research and adjustments, using words like 'hopeful' and 'much to tweak,' which indicate a balanced view of promise and challenge.
Posts generally express cautious optimism about the potential of CD19 CAR-T therapy for conditions beyond leukemia, such as multiple sclerosis, showing some support for ongoing research.
Discussions indicate a moderate level of curiosity about the therapy's possibilities, with some posts highlighting its hopeful aspects while acknowledging the need for further investigation.
Participants reference specific studies and mention the need for tweaks and more research, reflecting a genuine interest and active engagement.
The discussions suggest that these developments could influence future treatments, but the overall impact is seen as promising yet preliminary.
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis CD19 CAR-T cell therapy showed some promise, tested in 2 MS patients. There is much to tweak and investigate, but it is hopeful. www.cell.com/med/ful... 1/2
This video provides an educational overview of immuno-oncology principles, focusing on CD19-targeted CAR T-cell therapy for acute lymphoblastic leukemia, highlighting its promising remission rates, challenges like…
This video covers fundamental concepts in immuno-oncology, including the role of immune responses and cytokine pathways in cancer treatment, emphasizing recent advances such as CD19-targeted CAR T-cell therapy for acute…
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis CD19 CAR-T cell therapy showed some promise, tested in 2 MS patients. There is much to tweak and investigate, but it is hopeful. www.cell.com/med/ful... 1/2